Highlights in SCLC from ESMO 2018
26 Oct 2018
Highlights in SCLC from ESMO 2018
Safety analysis of entrectinib for NTRK fusion tumours
CheckMate142: Checkpoint combination therapy in first-line colorectal cancer
20 year followup on high-dose chemo with HSCT in high-risk breast cancer
Opportunities for biosimilars in practice and education
Recent advances in CNS tumour management
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma
Cisplatin superior to cetuximab for HPV oropharyngeal cancer
ESMO 2018: Melanoma highlights
Advances in metastatic non small cell lung cancer
Detecting copy number alterations using a pre-natal test
PEACE: Collecting cancer tissue to solve the riddle of metastasis